共 97 条
[1]
Whiteford HA(2013)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 Lancet 382 1575-1586
[2]
Degenhardt L(2012)Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries Bull World Health Organ 90 47-54B
[3]
Rehm J(2013)Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies Drugs 73 1549-1568
[4]
Lora A(2014)What does universal health coverage mean? Lancet 383 277-279
[5]
Kohn R(2016)Universal health coverage for schizophrenia: a global mental health priority Schizophr Bull 42 885-890
[6]
Levav I(2014)Monitoring and evaluating progress towards universal health coverage in Chile PLoS Med 11 e1001676-1469
[7]
Jesus Mari J(2011)Adherence to guidelines and treatment compliance in the Chilean national program for first-episode schizophrenia PS 62 1463-843
[8]
Tófoli LF(2002)Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature Can J Psychiatry 47 833-1370
[9]
Noto C(2006)Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study Am J Psychiatry 163 1362-287
[10]
O’Connell T(2020)The incidence of non-affective psychotic disorders in Chile between 2005 and 2018: results from a national register of over 30000 cases Psychological Med 12 271-S166